March 25th, 2014
ESTERN Medical CRO Appoints Clinical Trials Senior Executive Dr. Charles Schmidt, MD to Head Lead Scientific Global CRO, R&D & Consulting for Latin America

ESTERN Medical, , a therapeutically focused International Contract Research Organization (CRO) with a trusted scientific R&D knowledge for delivering reliable results, today announced the appointment of Dr. Charles Schmidt as the "Head Scientific Medical Advisor", based in Sao Paulo, Brazil. Dr. Schmidt will leverage his extensive clinical research background within the pharmaceutical & medical device and CRO industries to lead ESTERN Medical CRO & consulting unit in Latin America. This business unit is responsible for providing biopharmaceutical & medical device customers with world-class R&D in the areas of clinical drug development, medical devices, commercialization and regulatory submissions.

"Making informed decisions regarding product or portfolios clinical trials R&D development is just one of many challenges that pharmaceutical & medical device executives must address to remain competitive and maximize their return on investment," said Dr. Jorge Estrella, President & Chief Medical Officer at ESTERN Medical. "We're excited to have Dr. Schmidt on board to provide his expertise perspective in using new methods to increase clinical trial efficiency to expand the breadth of support to our customers. ESTERN Medical has continued to strengthen our CRO & consulting practices with a number of senior appointments, including Dr. Schmidt. His leadership and broad clinical, pharmaceutical & medical device background will be instrumental as we look to expand our integrated services model to include clinical development optimization and compliance. These additions, combined with our strategy, LATAM QA and regulatory practice areas, provide the complete framework to address our customers' most pressing business needs in Pharmaceutical development & medical device today."

Dr. Schmidt has more than 25 years' experience in the clinical, central lab, pharmaceutical, CRO & medical device industry. Prior to joining ESTERN Medical, he served as Head of Outsourcing at a major US & European biopharmaceutical companies at Abbott Labs, Quintiles, PRA International, Medpace & Eurotrials. Having worked for both, pharma & medical device companies and international CROs, Dr. Schmidt has broad industry expertise and has held senior management positions in a range of functions, including clinical project and operations management, clinical development, strategic business planning and international clinical affairs.

Dr. Schmidt is the founder & former president of the Brazilian Association of CROs (ABRACRO). Member of the board and Director of the Brazilian Association of Pharmaceutical Physicians (SBMF) and member of the steering committee of DIA Latin America on the discovery, development, evaluation and utilization of medicines and related health care technologies.

Dr. Schmidt received his Medical degree from the University Faculdade de Ciências Médicas da Santa Casa School of Medicine in Sao Paulo (Brazil) and did further medical and research training (Master and Doctorate degree) in Pediatrics & Infectious Diseases at the Universidad Federal de Sao Paulo in Brazil (UNIFESP). Addition to his clinical background, he received degree in Post-graduate Management at the Faculdade de Saúde Pública da USP Brazil. He is currently a professor & coordinator of the post-graduate program in clinical research at the University - Faculdade de Ciencias Medicas da Santa Casa in Sao Paulo, Brazil.

April 20th, 2011
ESTERN Medical CRO Group, Newest clinical research organization business partnership alliance with European Spanish Salutis International CRO bringing Europe and Latin America closer together to our Sponsors.

Boston, MA., ESTERN Medical CRO and Spanish Salutis International CRO., have announced a new business collaboration, aimed towards expanding expertise in the clinical research trials in both geographic regions in Latin America and Europe.

Salutis International S.L., is a privately owned, full-service CRO with headquarters in Barcelona, Spain, with offices in Madrid and Coimbra (Portugal).

With this alliance both companies will offer customised, flexible solutions for complex clinical studies. Both, ESTERN & Salutis, are committed in meeting the clients' needs not only in the Latin-Iberican-Portugues populations both beyond such borders and regions.

Our global sponsors are more at ease with a CRO that have multi regional presence and offer end to end services. We are able to address this need, with the support of Salutis a highly reputed CRO in the Iberian Peninsula of Europe.

ESTERN Medical CRO & Salutis International CRO look forward in working together in two of the top competitive markets. Dr. Jorge Estrella MD., ESTERN Medical, President & Chief Medical Officer & Dr. Oriol Ros MD., MBA., Salutis International Business Development Director commented that this will a beneficial business relationship for both of our companies to provided this new portfolio to the clinical trials research industry.

April 1st, 2011
ESTERN Medical CRO Corporate in Boston, USA, announce that staring April/01/2011, "ESTERN De Colombia S.A.S." regional division will relocate its Bogota, Colombian regional offices to its new Bogota, Chico building, As part of ESTERN'S business offices restructuring across South America.

The newer Colombian offices are located at the Antiguo Country sector in the North Zone of Bogota, in the financial and commercial hearth district of the Capital of Colombia.

Dr. Jorge Estrella MD., ESTERN Medical Group, President & Chief Medical Officer & Dr. Hernan Dario Hernandez., Director Operations South America commented that ESTERN is constantly modernizing its physical business structure to serve its clients with constant dynamism for our internal and external business partners & sponsors globally.

March 29th, 2011
Dr. Juan E. Gutierrez MD Joins Diagnostic Radiological Imaging Corporate Scientific Advisory Leadership Team at ESTERN Medical CRO.

Therapeutic and Operational Clinical Trials Expert Strengthens Diagnostic Radiological Imaging Capabilities.

Boston, MA, USA- ESTERN Medical, LLC & Global Subsidiaries., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, welcomes Dr. Juan Gutierrez MD as Senior Advisor Diagnostic Radiological Imaging, who will be leveraging his extensive radiological trial experience for Phase I first-inman studies through pivotal global Phase IV programs.

"Our reputation as leaders in supporting complex radiological clinical trials enables us to attract proven leadership talent experts like Dr. Gutierrez to join our team and support continued growth and excellence as an Radiological Expertise CRO," said Dr. Jorge Estrella MD, President & Chief Medical Officer at ESTERN Medical. "His experience will be a great asset to help us keep pace with advancements in radio-pharmaceuticals and CT, MRI / MRA clinical trial development design, particularly as early phase research is playing a more significant role to better help reduce risk in later phases, and to provide thoughtful support to our clients."

Dr. Gutierrez has nearly 15 years experience in clinical drug development in the fields of radiology and oncology. Previously at Bayer Health Care Pharmaceuticals (Former Berlex Laboratories)as the Director Medical Development Diagnostic Imaging, Dr. Gutierrez held increasing responsibilities for the operations, strategic planning and corporate development of a growing portfolio of radiopharmaceutical business. His key early phase experience includes multiple variations of early-phase Cardiology, CNS and Oncology trial designs including traditional dose-escalating maximum tolerated dose design as well as various optimal dose designs for targeted agents.

Dr. Gutierrez later phase oncology, cardiology & CNS experience includes extensive pivotal trial experience in the United States, Western and Eastern Europe, Latin America, and Asia-Pacific. With such clinical trials projects under his belt of clinical design and global implementation with Bayer Health Care (e.g. Vasovist, Magnevist, Gadovist, Ultravist and Iopamiron and Also with Guerbet Pharma Group with Dotarem).

As a clinician, scientist and investigator, Dr Gutierrez focus his knowledge with the clinical community with a bast track record of scientific clinical journals and book publications.

Dr. Gutierrez holds a fellowship Interventional Radiology at the Jacksonville Memorial Hospital at Miami, Florida a Neuroradiology Research Fellowship from Thomas Jefferson University in Philadelphia. He received his medical degree from the CES University in Medellin, Colombia and he completed residency training in Clinical Radiology at the Javeriana Pontificial University in Bogota, Colombia.

Dr. Gutierrez is currently an Assistant Professor of Radiology Division of Neuroradiology at The University of Texas Health Science Center in San Antonio, Texas, US

Dr. Jorge Estrella M.D., ESTERN Medical, President & Chief Medical Officer , commented that he is thrilled to have Dr. Juan E. Gutierrez on the Corporate & Scientific Advisory Board at ESTERN Medical and looks forward to be working with Dr. Gutierrez who brings additional medical expertise into the company structure.

Dr. Gutierrez and I share a vision which is to improve the Diagnostic Radiological Imaging Clinical Research and quality of lives of people by applying our synergy of knowledge in this field for our pharmaceutical and medical device sponsors treatments to for present and future pipelines in new treatment indications.

February 16th, 2011
ESTERN Medical, Head of Corporate Advisory Board, Mr. Michael D. Webb was appointed as one of the Main Advisory Board for The University of Kansas City Institute for Advancing Medical Innovation (IAMI)

Boston, Massachusetts., Inspired by the opportunity to grow educational and entrepreneurial capacity, the Institute for Advancing Medical Innovation (IAMI) was established upon the belief that: "ideas are translated to innovation to improve health". The Institute will focus on education and research that advances medical innovations. The result will ultimately accelerate the number and quality of new drugs, medical devices and drug

December 8th, 2010

Boston, MA., Beyond visiting a Contract Research Organization and experiencing our CRO in the Web or in person, the next best thing is the new, which launched this early north america winter, just as ESTERN Medical are evolving, the site matures with a progressive user interface, modern functionally and visually engaging product presentations.

Dr. Jorge Estrella MD., President and Chief Medical Officer, comment likely the first thing you'll noticed is the abundance of stunning images and updated information. On average, each page of information that gives you a brilliant visual experience. And if you like what you see, take it with you in a dynamic print-out. "As you browse the full-screen images you can share and solicit feedback from any social network like Facebook, Twitter, Linkedin, Xing and CenterWatch says Mr. Roman Tienda, Director Business Communications & IT. When you want to dig a little deeper, the new configuration allows you to quickly browse detail any clinical, regulatory type of information with different trim levels as well as facts in the Latin American CRO market.

Dr. Estrella comment we at ESTERN Medical are happy that "In real-time, a client can see how other people are configuring a clinical trial across Latin America, It's a modern twist on social networking that hasn

 First Previous Next Last

Warning: mysql_free_result(): 5 is not a valid MySQL result resource in /nfs/c09/h01/mnt/188747/domains/ on line 160